Lamprene

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1970-2017
02419702017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Clofazimine (Lamprene) is an antimycobacterial drug that has antiinflammatory activity in a number of chronic autoimmune skin… (More)
  • table 2
  • table 1
  • table 3
Is this relevant?
1988
1988
Clofazimine (Lamprene, B663) and 11 rimino-compounds were tested for activity against Mycobacterium avium by finding the minimal… (More)
Is this relevant?
1987
1987
The authors report 3 cases of temporary generalized lymphoadenopathy directly related to Lamprene (Clofazimine) consumption. It… (More)
Is this relevant?
1986
1986
Bull's-eye retinopathy has multiple associations. We report a case of bull's-eye retinopathy presumed to be secondary to… (More)
Is this relevant?
1983
1983
A 46-year-old woman with widespread prurigo nodularis was treated with 300 mg clofazimine a day for six months. Ten months after… (More)
Is this relevant?
1981
1981
A 33 year old male Nigerian presented with widespread involvement of peripheral nerves, several of which were tender and painful… (More)
  • figure 2
  • figure 3
Is this relevant?
1980
1980
A male patient 68 years, suffering from pyoderma gangrenosum which was resistant to conventional treatment, received clofazimine… (More)
Is this relevant?
1978
1978
Lamprene (Clofazimine) was administered over a period of three months, at a dose of 100 mg to 200 mg per day, to six patients… (More)
Is this relevant?
1975
1975
Die Rimino-Phenazin-Verbindung (Präparat B663 — Lampren® Clofazimine) mit starker Wirkung gegenMycobacterium leprae wurde 41/2… (More)
Is this relevant?
1975
1975
Patients receiving Lamprene may develop acute abdominal symptoms which simulate an abdominal emergency. Withdrawal of the drug… (More)
Is this relevant?